| |
| |
|
| Insider
Information: |
Spickschen Thorlef |
| Relationship: |
Director |
| City: |
Germany |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
58,176 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$873 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,176 |
|
|
| Total
Value |
$873 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Director |
2008-03-07 |
0 |
2004-11-05 |
0 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
Director |
2019-08-16 |
58,176 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2019-08-16 |
4 |
B |
$5.67 |
$48,762 |
D/D |
8,600 |
58,176 |
2.39 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2019-08-14 |
4 |
B |
$5.46 |
$50,232 |
D/D |
9,200 |
49,576 |
2.39 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2019-01-03 |
4 |
OE |
$0.29 |
$28,740 |
D/D |
32,758 |
40,376 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2018-04-09 |
4 |
AS |
$60.02 |
$270,090 |
D/D |
(4,500) |
7,618 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2018-03-08 |
4 |
AS |
$61.47 |
$276,615 |
D/D |
(4,500) |
12,118 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2018-02-22 |
4 |
AS |
$60.00 |
$270,000 |
D/D |
(4,500) |
16,618 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2018-01-08 |
4 |
AS |
$64.97 |
$292,365 |
D/D |
(4,500) |
21,118 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2017-12-08 |
4 |
AS |
$60.00 |
$270,000 |
D/D |
(4,500) |
25,618 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2015-05-13 |
4 |
S |
$85.00 |
$366,270 |
D/D |
(4,309) |
30,118 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2013-12-05 |
4 |
S |
$55.96 |
$335,787 |
D/D |
(6,000) |
34,427 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2013-12-04 |
4 |
S |
$56.38 |
$169,138 |
D/D |
(3,000) |
40,427 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2011-11-21 |
4 |
B |
$13.00 |
$173,017 |
D/D |
13,309 |
43,427 |
2.39 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
Director |
– • – |
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
30,118 |
30,118 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,750) |
0 |
0 |
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2005-08-26 |
4 |
OE |
$1.60 |
$42,500 |
D/D |
18,750 |
18,750 |
|
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2004-11-05 |
4 |
S |
$48.00 |
$601,246 |
D/D |
(12,500) |
0 |
|
- |
|
| WTKND |
Welltek Incorporated |
Director |
– • – |
2004-11-05 |
4 |
OE |
$1.60 |
$21,500 |
D/D |
12,500 |
12,500 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
